Drug Trial Radar · NCT00570765
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
Last checked: Nov 19, 2026Latest source record: Jun 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Jan 17, 2008
Primary completion
Sep 21, 2010
Study completion Sep 25, 2017
Sponsor
- Lead sponsor
- Intercept PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Dec 11, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary hypothesis was that obeticholic acid (OCA) will cause a reduction in alkaline phosphatase levels in PBC participants, over a 12-week treatment period, as compared to placebo.
Conditions
- Liver Cirrhosis, Biliary
Interventions
PlaceboDrug
Matching placebo tablets were administered orally once daily.
Obeticholic Acid (OCA)Drug
Starting dose of 10 or 50 mg administered orally once daily, followed by dose titration planned from 10 mg to 25 mg to 50 mg once daily, which could be modified for safety and tolerability issues or to achieve adequate therapeutic response.
Primary outcomes
What the sponsor says the trial is designed to measure.
- DB Phase: Mean Percent Change In Serum Alkaline Phosphatase (ALP) From Baseline To Day 85Time frame: Baseline, Day 85
Locations
21 sites in 7 countries. Site status is shown where the registry gives one.
Henry Ford
Detroit, Michigan
Baylor College of Medicine
Houston, Texas
Virginia Commonwealth University
Richmond, Virginia
Virginia Mason Medical Center
Seattle, Washington
Karls-Franzens University
Graz, Austria
University of Alberta
Edmonton, Alberta, Canada
University of Toronto
Toronto, Ontario, Canada
Centre de Recherche du CHUM / University of Montreal
Montreal, Quebec, Canada
Hopital de l'Hotel Dieu
Lyon, France
Hopital Saint-Antoine
Paris, France
Johann Wolfgang Goethe University
Frankfurt, Germany
University Medical Centre Hamburg-Eppendorf
Hamburg, Germany
Medical School of Hannover
Hanover, Germany
University of Munich
Munich, Germany
Hospital Clinic i Provincial
Barcelona, Spain
Royal Infirmary
Edinburgh, United Kingdom
Sunderland Research Ethics Committee
Jarrow, United Kingdom
University Upon Tyne/Newcastle
Newcastle upon Tyne, United Kingdom
Queen Elizabeth Medical Center
Edgbaston, Birmingham, United Kingdom
Royal Free Hospital
Hampstead, London, United Kingdom
John Radcliffe Hospital
Headington, Oxford, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.